ZYBT — Zhengye Biotechnology Holding Cashflow Statement
0.000.00%
Last trade - 00:00- $492.42m
- $492.44m
- CNY0.21m
Annual cashflow statement for Zhengye Biotechnology Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 0.046 | 0.056 | 0.038 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 0.004 | 0.011 | 0.007 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.034 | -0.067 | -0.02 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 0.032 | 0.017 | 0.048 |
| Capital Expenditures | -0.026 | -0.027 | -0.012 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0 | 0 | -0 |
| Sale of Fixed Assets | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -0.026 | -0.027 | -0.012 |
| Financing Cash Flow Items | 0 | 0 | -0.004 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -0.003 | 0.013 | -0.019 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.002 | 0.003 | 0.017 |